Texas A&M Football Recruiting

H-Town Rundown: A&M's recruiting success in Houston remains vital

For Texas A&M, the greater Houston area is a vital recruiting ground as top prospects from all over the area are high on the Aggies' board. With the 2024 cycle in full swing, Ryan Brauninger lists a number of names to know from the Bayou City as the Ags are busy in H-Town.
By Ryan Brauninger
April 11, 2023
5.4k Views
Discuss
Story Poster

It's hard to imagine Texas A&M recruiting at a high level without heavy involvement in the city of Houston. From Katy to Mont Belvieu, from Conroe to Galveston, it's imperative for the Aggies to make H-town a priority each and every year.

We all know how much was pulled from the city to build the historic 2022 class, but even last cycle when the talent across the Bayou City was down a tick, Jimbo Fisher & Co.

To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Terry Price D.J. Durkin Elijah Robinson TJ Rushing Bryant Gross-Armiento Jimbo Fisher H-Town Rundown Kenyon Green Kam Dewberry Noah Thomas Daymion Sanford David Hicks
Show All
Rueben Owens Nate Kibble Ian Flynt Gibson Pyle Jelani Watkins Chad Woodfork Tory Blaylock Ashton Funk Maurice Williams Rodney Bimage Mason Dossett JaKayden Ferguson Andrew Marsh Xavier Atkins Loghan Thomas Devin Sanchez Blake Ivy Josh Moses Deion DeBlanc Chad Gasper Deyjhon Pettaway Joseph Jonah-Ajonye Landon Rink Bennett Warren Jonah Williams Josh Lair Football Recruiting 2024 2025
More Football Recruiting
See All →
TexAgs HS Football Thread: Week 4
By Cade Draughon
A&M coaches on the road during bye week
By Ryan Brauninger
Recruiting Country: The latest recruiting news surrounding the Maroon & White
By Ryan Brauninger
There is recruiting momentum to be seized by A&M during the bye week
By Jason Howell
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.